// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

The RNA binding Protein ANKHD1 provides vasoprotection via enhancing eNOS and PTGIS

Areej Alahmadi - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Prostacyclin

Glycocalyx depth assessment in pig blood vessels for vein graft applications

Nathalie Tarassova - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Enhanced matrix stiffness prevents vsmc contractility how calcium signalling and microtubule stability regulate vascular compliance during ageing

Robert Johnson - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Calcified vascular disease

Angiotensin II

Histone deacetylase 6 inhibition induces dna damage accumulation in aortic smooth muscle cells

Reesha Solanki - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Dexamethasone inhibits opn activation associated with intimal hyperplasia in vein grafts

Liam McQueen - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Intimal hyperplasia

Dexamethasone

Endothelial cell profile in responses to high shear stress is different in healthy arteries and plaques

Ziqi Zhou - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Matrix stiffness drives increased vascular smooth muscle cell volume response via aquaporin mediated water influx

Finn Wostear - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Spatial transcriptomics provides a mechanistic insight into SOX9 mediated cardiac fibrosis

Lina Laid - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac fibrosis

N/A

T1 mapping in a mouse model of myocardial infarction model using variable flip angle manganese enhanced MRI

Shahrani Janudin - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Human macrophages are immunoprofiled by pericardial fluid small extracellular vesicles modulating lipid metabolism mechanisms

Soumaya Ben-Aicha - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Echocardiographic evaluation of left ventricular function and myocardial deformation in a reperfused mouse model of myocardial infarction

Zhiping Feng - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

FLT4 pleiotropy in congenital cardiac or lymphovascular disease is mediated through distinct cellular mechanisms

Richard Monaghan - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Salt inducible kinase 2 SIK2 as a new putative therapeutic target for heart failure

Cecilia Facchi - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

ARN-3236

MARK4 controls ischaemic heart failure through microtubule detyrosination

Xuan Li - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

Cyclic amp increases nuclear actin monomer which promotes proteasomal degradation of rela p65 leading to anti inflammatory effects

Mark Bond - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Antiplatelets and risk of cancer a national propensity score weighted cohort analysis

Clare Oliver-Williams - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Myocardial infarction

Ticagrelor

The role of the lncrna eincr1 and mapk signalling in the heart

Hayden Jones - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Acute arterial haemodynamics activation of endothelial to mesenchymal transition in long saphenous veins Impact on vein graft disease

Shameem Ladak - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Leukocytic nitrate reductase activity mitigates systemic inflammation induced endothelial dysfunction in humans by accelerating resolution

Asad Shabbir - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Vasodilation dysfunction

Typhoid vaccine

Prevalence and diagnostic significance of novel 12 lead ECG patterns following COVID 19 infection in elite soccer players

Raghav T Bhatia - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Progressive cardiac conduction defect

N/A

Copyright © 2026. QuantiNova All rights reserved